The development of an HIV vaccine has been marked by both long-standing and emerging challenges and opportunities. In this video, Sanchia Theron, Global Head, Medical Affairs, and Andy Fleming, Senior Account Development Manager, discuss major takeaways from our roundtable discussion at World Vaccine Congress Washington: 40+ Years and Still no HIV Vaccine: Has Patience Been a Virtue?
To achieve our vision of a world where advances in vaccines help all people live longer, healthier lives, we’ve honed our processes to respond to the urgency and complexity of vaccine trials, developed our global network of investigators and sites, and partnered with organizations across public, private, academic and government sectors.
Participant recruitment and retention can be challenged by many factors such as a long follow-up period, lack of accessible sites and unclear expectations. Our team helps develop and implement agile solutions to overcome these difficulties, as described in this video for multiple studies including a global, multi-site oncology trial.
Investigating existing treatments for their efficacy to treat COVID-19 is important in some countries with limited access to new treatments, such as Ghana. In this project profile, Loice Magaria, Clinical Research Project Manager at FHI Clinical, discusses a study we’re supporting in Ghana to investigate COVID-19 treatments.
With infectious disease outbreaks, expanding immunity from previous infection and vaccination efforts can change where the outbreak is occurring. In this video, Loice Magaria, Clinical Research Project Manager at FHI Clinical discusses strategies implemented to address changing epidemiology in a study investigating COVID-19 treatments.
Cultural competence is important when interacting with local communities in a research setting. Our localized team members provide valuable insight into the language and culture of their communities and are skilled at cultural humility when working with teams and populations in other regions.
In this video, FHI Clinical experts share their final thoughts following a fall 2021 trip to Liberia to visit the PREVAIL network of sites and staff.
Watch this video to hear FHI Clinical experts detail upcoming research projects the PREVAIL network is excited to embark on, including a Lassa fever program.
FHI Clinical experts discuss their observations on the effects of COVID-19 on the local healthcare system during their fall 2021 visit to the Liberian PREVAIL sites.
Hear from a team of FHI Clinical experts as they discuss the importance of having localized expertise on the ground to build research capacity and site sustainability.
FHI Clinical Headquarters
359 Blackwell Street, Suite 200
Durham, NC 27701 USA